HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elise A Olsen Selected Research

Antipruritics

11/2012Aprepitant: a novel neurokinin-1 receptor/substance P antagonist as antipruritic therapy in cutaneous T-cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elise A Olsen Research Topics

Disease

10Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
03/2013 - 03/2002
9Alopecia (Baldness)
02/2020 - 09/2002
5Mycosis Fungoides
01/2016 - 07/2007
4Neoplasms (Cancer)
02/2018 - 03/2002
3Alopecia Areata
02/2020 - 06/2004
3Lymphoma (Lymphomas)
01/2017 - 02/2011
3Pruritus (Itching)
07/2007 - 03/2002
2Disease Progression
05/2013 - 07/2007
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2022
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2022
1Enteropathy-Associated T-Cell Lymphoma
01/2022
1Lymphadenopathy
11/2020
1Extranodal NK-T-Cell Lymphoma
02/2018
1Skin Neoplasms (Skin Cancer)
01/2016
1Inflammation (Inflammations)
04/2014
1Breast Neoplasms (Breast Cancer)
07/2011
1Drug-Related Side Effects and Adverse Reactions
04/2010
1Exanthema (Rash)
12/2009
1Pulmonary Embolism
12/2009
1Anorexia
12/2009
1Thrombocytopenia (Thrombopenia)
12/2009
1Cicatrix (Scar)
07/2008
1Psoriasis (Pustulosis Palmaris et Plantaris)
03/2008

Drug/Important Bio-Agent (IBA)

5Minoxidil (Rogaine)FDA LinkGeneric
07/2016 - 09/2002
4denileukin diftitox (Ontak)FDA Link
03/2013 - 03/2002
3Finasteride (Propecia)FDA LinkGeneric
09/2012 - 03/2003
2SolutionsIBA
07/2016 - 09/2002
2Dutasteride (Avodart)FDA Link
05/2013 - 12/2006
2Histone Deacetylase InhibitorsIBA
12/2009 - 07/2007
2VorinostatFDA Link
12/2009 - 07/2007
2InterferonsIBA
12/2003 - 01/2003
1Anaplastic Lymphoma KinaseIBA
01/2022
1ruxolitinibIBA
02/2020
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2017
1SaltsIBA
12/2016
1AndrogensIBA
04/2014
1Carmustine (FIVB)FDA Link
01/2013
1Mechlorethamine (Nitrogen Mustard)FDA Link
01/2013
1AntipruriticsIBA
11/2012
1Substance PIBA
11/2012
1Aprepitant (Emend)FDA Link
11/2012
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
11/2012
1Busulfan (Busulfex)FDA Link
07/2011
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2011
1ErbB Receptors (EGF Receptor)IBA
04/2010
1CreatinineIBA
12/2009
1Anti-Bacterial Agents (Antibiotics)IBA
07/2008
1Adrenal Cortex Hormones (Corticosteroids)IBA
07/2008
1efalizumab (Raptiva)FDA Link
03/2008
1Propylene Glycol (1,2 Propanediol)FDA LinkGeneric
11/2007
1antineoplaston A10 (A 10)IBA
07/2007
1thiamine triphosphorate (TTP)IBA
07/2007
1Dihydrotestosterone (Androstanolone)IBA
12/2006
1Fluorouracil (Carac)FDA LinkGeneric
06/2004
1Interleukin-12 (IL 12)IBA
12/2003
1Interleukin-2 (IL2)IBA
12/2003
1CytokinesIBA
12/2003
1Peptides (Polypeptides)IBA
01/2003
1Proteins (Proteins, Gene)FDA Link
03/2002
1Interleukin-2 Receptors (IL 2 Receptor)IBA
03/2002

Therapy/Procedure

12Therapeutics
02/2018 - 03/2002
3Drug Therapy (Chemotherapy)
11/2020 - 07/2011
1Phototherapy (Light Therapy)
01/2016
1Radiotherapy
01/2016
1Retreatment
03/2013
1Aftercare (After-Treatment)
12/2009